Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - LONG-TERM INVESTMENTS
Long-term Investments ALLO - Allogene Therapeutics, Inc.
3.64 M
LAST VALUE
-90.08%
2 YEAR CAGR
-57.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR